Design Therapeutics, Inc. (DSGN) Tops Q2 EPS by 3c
Get Alerts DSGN Hot Sheet
Join SI Premium – FREE
Design Therapeutics, Inc. (NASDAQ: DSGN) reported Q2 EPS of ($0.32), $0.03 better than the analyst estimate of ($0.35).
For earnings history and earnings-related data on Design Therapeutics, Inc. (DSGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fluent (FLNT) Tops Q2 EPS by 4c
- Verde Clean Fuel (VGAS) Misses Q2 EPS by 4c
- Septerna, Inc. (SEPN) Tops Q2 EPS by 45c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share